1. Home
  2. ICFI vs VIR Comparison

ICFI vs VIR Comparison

Compare ICFI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$89.73

Market Cap

1.3B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.73

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICFI
VIR
Founded
1969
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
ICFI
VIR
Price
$89.73
$9.73
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$99.25
$19.43
AVG Volume (30 Days)
207.7K
1.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
0.82%
N/A
EPS Growth
N/A
17.49
EPS
2.61
N/A
Revenue
$1,229,162,000.00
$68,556,000.00
Revenue This Year
$4.12
$270.22
Revenue Next Year
$5.33
N/A
P/E Ratio
$34.13
N/A
Revenue Growth
3.72
N/A
52 Week Low
$58.83
$4.35
52 Week High
$101.50
$11.66

Technical Indicators

Market Signals
Indicator
ICFI
VIR
Relative Strength Index (RSI) 60.23 58.52
Support Level $84.28 $9.51
Resistance Level $89.91 $9.80
Average True Range (ATR) 3.34 0.42
MACD -0.31 0.10
Stochastic Oscillator 53.91 77.13

Price Performance

Historical Comparison
ICFI
VIR

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: